D. Pye

发表

Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus

S. Edwards, D. Love, J. M. Whalley, 2005, Archives of Virology.

Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity.

A. Saul, R. Mollard, D. Pye, 1990, Immunology letters.

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.

R. Anders, P. Schoofs, A. Saul, 1999, Vaccine.

Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea.

M. Alpers, B. Genton, R. Anders, 2000, Vaccine.

Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.

A. Saul, G. Lawrence, D. Pye, 1997, Vaccine.

Inactivation of poliovirus with β-propiolactone

D. Pye, J. Cox, Jiang De, 1986 .

Simple diagnostic test for antibodies to Encephalitozoon cuniculi based on enzyme immunoassay

R. Horsburgh, D. Pye, J. Cox, 1981, Laboratory animals.

Isolation of Encephalitozoon cuniculi from urine samples

D. Pye, J. Cox, 1977, Laboratory animals.

Application of immunofluorescence to the establishment of an Encephalitozoon cuniculi-free rabbit colony.

D. Pye, J. Cox, H. A. Gallichio, 1977, Laboratory animal science.

An investigation of Encephalitozoon cuniculi in the wild rabbit Oryctolagus cuniculus in Victoria, Australia

D. Pye, J. Cox, R. Shepherd, 1980, Journal of Hygiene.

Simple Focus Assay for Encephalitozoon Cuniculi

D. Pye, J. Cox, 1979, Laboratory animals.

Serodiagnosis of nosematosis by immunofluorescence using cell-culture-grown organisms

D. Pye, J. Cox, 1975, Laboratory animals.

SERODIAGNOSIS OF NOSEMATOSISBY IMMUNOFLUORESCENCEUSING CELL-CULTURE-GROWNORGANISMS

D. Pye, J. Cox, 1975 .

The infectivity ofEncephalitozoon cuniculi in vivo and in vitro

D. Pye, J. Cox, R. C. Hamilton, 2004, Zeitschrift für Parasitenkunde.

Inactivation of poliovirus with beta-propiolactone.

D. Pye, J. Cox, S. Jiang, 1986, Journal of biological standardization.

Rapid detection and isolation of mycoplasmas from cell cultures.

D. Pye, G. Tomkins, A. Macgregor, 1975, The Australian journal of experimental biology and medical science.

Marsupial cells in long-term culture

D. Pye, J. F. Stanley, A. Macgregor, 1977, In Vitro.

Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia.

R. Anders, S. Edwards, A. Lew, 1989, Journal of immunology.

Comparison of doubling numbers attained by cultured animal cells with life span of species

D. Pye, J. F. Stanley, A. Macgregor, 1975, Nature.

Simple and rapid evaluation of serum for cell culture.

D. Pye, 1975, Journal of biological standardization.

Changes in Simian Virus 40 susceptibility and chromosome numbers during long-term cultivation of BS-C-1 cells.

D. Pye, G. Tomkins, 1968, Journal of the National Cancer Institute.

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

Thomas A. Smith, M. Alpers, B. Genton, 2002, The Journal of infectious diseases.

Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.

R. Anders, S. Edwards, P. Crewther, 1998, Vaccine.

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children.

Thomas A. Smith, M. Alpers, B. Genton, 2003, Vaccine.

A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant.

V. Murphy, R. Anders, P. Crewther, 2005, Vaccine.

Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.

R. Coppel, S. Edwards, P. Crewther, 1994, The American journal of tropical medicine and hygiene.

Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

Andreas Suhrbier, John J Miles, S. Burrows, 2007, Journal of Virology.

A marsupial oncovirus?

D. Pye, R. C. Hamilton, A. Macgregor, 1979, The Journal of general virology.

Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.

R. Anders, C. Alving, R. Richards, 1997, Vaccine.

Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria

R. Anders, S. Edwards, C. Monger, 1991, Infection and immunity.

Procedures for evaluating growth-promoting qualities of cell culture reagents

D. Pye, 1976 .

Development of a vaccine preventing parvovirus-induced reproductive failure in pigs.

S. Edwards, D. Pye, J. Bates, 1990, Australian veterinary journal.

Isolation of parainfluenza virus from dogs.

H. Smith, D. Pye, P. Scott, 1985, Australian veterinary journal.

Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus

D. Boyle, S. Edwards, D. Love, 1993, Journal of virology.

Quantitative evaluation of serum for cell culture.

D. Pye, 1977, Journal of biological standardization.

Plasmodium falciparum infection of splenectomized and intact Guyanan Saimiri monkeys.

R. Anders, C. Monger, D. Pye, 1994, Journal of Parasitology.

High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate.

A. Saul, D. Pye, G. Jones, 1989, Peptide research.

Cell lines for growth of sheep viruses.

D. Pye, 1989, Australian veterinary journal.

Chimeric potyvirus-like particles as vaccine carriers.

C. Ward, P. Schoofs, S. Edwards, 1996, Intervirology.

The development and evaluation of a cell culture vaccine against infectious laryngotracheitis virus.

G. Tannock, D. Pye, M. Wark, 1979, Journal of biological standardization.

Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum.

A. Saul, D. Stenzel, D. Pye, 1989, Journal of Immunology.